Towards superior dendritic-cell vaccines for cancer therapy
Nat Biomed Eng
.
2018 Jun;2(6):341-346.
doi: 10.1038/s41551-018-0250-x.
Epub 2018 Jun 11.
Authors
Mansi Saxena
1
,
Sreekumar Balan
1
,
Vladimir Roudko
1
,
Nina Bhardwaj
2
3
Affiliations
1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
2
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. nina.bhardwaj@mssm.edu.
3
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. nina.bhardwaj@mssm.edu.
PMID:
30116654
PMCID:
PMC6089533
DOI:
10.1038/s41551-018-0250-x
No abstract available
Grants and funding
R01 AI081848/AI/NIAID NIH HHS/United States
R01 CA180913/CA/NCI NIH HHS/United States
R01 CA201189/CA/NCI NIH HHS/United States
T32 AI007605/AI/NIAID NIH HHS/United States